SG11202101391WA - Recombinant lectin variants - Google Patents

Recombinant lectin variants

Info

Publication number
SG11202101391WA
SG11202101391WA SG11202101391WA SG11202101391WA SG11202101391WA SG 11202101391W A SG11202101391W A SG 11202101391WA SG 11202101391W A SG11202101391W A SG 11202101391WA SG 11202101391W A SG11202101391W A SG 11202101391WA SG 11202101391W A SG11202101391W A SG 11202101391WA
Authority
SG
Singapore
Prior art keywords
recombinant lectin
variants
lectin variants
recombinant
lectin
Prior art date
Application number
SG11202101391WA
Other languages
English (en)
Inventor
Dhananjay Sathe
Sudeep Kumar
Original Assignee
Unichem Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unichem Lab Ltd filed Critical Unichem Lab Ltd
Publication of SG11202101391WA publication Critical patent/SG11202101391WA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056Lectin superfamily, e.g. CD23, CD72
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/178Lectin superfamily, e.g. selectins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/42Lectins, e.g. concanavalin, phytohaemagglutinin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726Lectins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202101391WA 2018-08-31 2019-08-30 Recombinant lectin variants SG11202101391WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201821032765 2018-08-31
PCT/IB2019/057314 WO2020044296A2 (en) 2018-08-31 2019-08-30 Recombinant protein variants

Publications (1)

Publication Number Publication Date
SG11202101391WA true SG11202101391WA (en) 2021-03-30

Family

ID=68344911

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202101391WA SG11202101391WA (en) 2018-08-31 2019-08-30 Recombinant lectin variants

Country Status (14)

Country Link
US (1) US11965003B2 (zh)
EP (1) EP3844183A2 (zh)
JP (1) JP7453213B2 (zh)
KR (1) KR20210052449A (zh)
CN (1) CN113383015B (zh)
AU (1) AU2019330367A1 (zh)
BR (1) BR112021003628A2 (zh)
CA (1) CA3108842A1 (zh)
EA (1) EA202190240A1 (zh)
MA (1) MA53498A (zh)
MX (1) MX2021002295A (zh)
SG (1) SG11202101391WA (zh)
WO (1) WO2020044296A2 (zh)
ZA (1) ZA202100859B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021015426A (es) * 2019-07-09 2022-01-24 Unichem Lab Ltd Formulaciones estables de proteinas recombinantes.
KR20230008072A (ko) 2020-05-07 2023-01-13 유니켐 레버러토리스 리미티드 항암 단백질
WO2022149068A1 (en) * 2021-01-07 2022-07-14 Unichem Laboratories Ltd Lectin protein for treatment and prevention of neurodegenerative diseases
EP4366699A1 (en) 2021-07-08 2024-05-15 Unichem Laboratories Ltd Recombinant proteins, compositions and methods of stabilization thereof
CA3227834A1 (en) * 2021-08-30 2023-03-09 Dhananjay Sathe Protein compositions for the treatment of inflammatory diseases
CA3229988A1 (en) 2021-10-01 2023-04-06 Dhananjay Sathe Recombinant glycan binding proteins and its use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3418296B1 (en) 2009-02-18 2024-07-03 Unichem Laboratories Limited Cancer cell binding recombinant lectins with antitumor activity and method of preparation
WO2014203261A2 (en) 2010-02-02 2014-12-24 Unichem Laboratories Ltd. Recombinant lectin and method of preparing thereof
CN103987855B (zh) * 2011-11-01 2017-04-26 独立行政法人产业技术综合研究所 未分化细胞检测方法及复合糖检测方法
CN107223019A (zh) * 2013-09-25 2017-09-29 胺细拉健康公司 用于维持和提高肌肉质量、强度和性能的组合物和制剂及其产生和使用方法
WO2015054507A1 (en) * 2013-10-10 2015-04-16 Pronutria, Inc. Nutritive polypeptide production systems, and methods of manufacture and use thereof

Also Published As

Publication number Publication date
KR20210052449A (ko) 2021-05-10
CN113383015A (zh) 2021-09-10
ZA202100859B (en) 2022-07-27
WO2020044296A2 (en) 2020-03-05
JP2021534776A (ja) 2021-12-16
CN113383015B (zh) 2023-06-20
US20210317171A1 (en) 2021-10-14
CA3108842A1 (en) 2020-03-05
EA202190240A1 (ru) 2021-08-09
MA53498A (fr) 2021-07-07
AU2019330367A1 (en) 2021-03-11
EP3844183A2 (en) 2021-07-07
US11965003B2 (en) 2024-04-23
WO2020044296A3 (en) 2020-04-23
JP7453213B2 (ja) 2024-03-19
MX2021002295A (es) 2021-04-28
BR112021003628A2 (pt) 2021-05-18

Similar Documents

Publication Publication Date Title
DK3467457T3 (en) Vibrationssensor
GB2577811B (en) Connection
SG11202101391WA (en) Recombinant lectin variants
CA185384S (en) Casque
CA185382S (en) Casque
CA185385S (en) Casque
PL3775433T3 (pl) Układ połączeń
DK3613739T3 (en) Integrin-antagonister
DK3753395T3 (en) Indvendigt luftstyringssystem
CA184989S (en) Uroflowmeter
DK3633783T3 (en) Universal-powerbank
CA184992S (en) Uroflowmeter
GB201719557D0 (en) Polypeptide
GB201707139D0 (en) Polypeptides
IL281762A (en) Arginase proteins1
DK3674425T3 (en) Stålwire
DK3570498T3 (en) Adaptivt hvac-styresystem
DK3578923T3 (en) Navigationssystem
GB201810052D0 (en) Polypeptide
GB201807046D0 (en) Combination
CA187782S (en) Pompon-maker
DK3542617T3 (en) Etikette
GB201819369D0 (en) Maglee plane
ZA201807385B (en) Spout assembly
GB201806655D0 (en) Polypeptide